AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17200148 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 4922
Study 15132761 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine (1.5 microg/kg, i.m.)
Number of subjects: 10
Study 15132761 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 10
Study 11983670 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil-propofol
Number of subjects: 140
Study 11983670 — intervention group
Group type: COMPARATOR
Intervention: fentanyl-propofol
Number of subjects: 140
Study 9613475 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group (engaged in discussion about guidelines)
Number of subjects: 191
Study 9613475 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive group (attended a lecture)
Number of subjects: 191
Study 9613475 — intervention group
Group type: COMPARATOR
Intervention: Control group (received neither guidelines nor educational contact)
Number of subjects: 191
Study 7641905 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogens (CE) alone (0.625 mg daily)
Number of subjects: 114
Study 7641905 — intervention group
Group type: COMPARATOR
Intervention: Conjugated estrogens (CE) plus medrogestone (5 mg during the last 12 days of each 28-day cycle)
Number of subjects: 114
Study 2653402 — intervention group
Group type: EXPERIMENTAL
Intervention: colchicine 0.5 mg bd for 1 week
Number of subjects: 13
Study 2653402 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 13
Study 943169 — intervention group
Group type: EXPERIMENTAL
Intervention: Urea-lactic acid ointment
Number of subjects: 0
Study 943169 — intervention group
Group type: COMPARATOR
Intervention: Base ointment
Number of subjects: 0
Study 31563959 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib plus fulvestrant
Number of subjects: 669
Study 31563959 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus fulvestrant
Number of subjects: 669
Study 29550911 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus acidophilus LA‐5 plus Bifidobacterium animalis subsp. lactis BB‐12)
Number of subjects: 54
Study 29550911 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch capsules)
Number of subjects: 54
Study 29550911 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 54
Study 28537654 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological immune-enhanced enteral nutrition (EIEN)
Number of subjects: 54
Study 28537654 — intervention group
Group type: COMPARATOR
Intervention: Parenteral nutrition (PN)
Number of subjects: 54
Study 25514700 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypromellose 2%
Number of subjects: 38
Study 25514700 — intervention group
Group type: COMPARATOR
Intervention: Control (simulation of the procedure)
Number of subjects: 38
Study 22878879 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-form Sun-style t'ai chi (SSTC)
Number of subjects: 42
Study 22878879 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual medical care)
Number of subjects: 42
Study 21922877 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 43
Study 21922877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 18940881 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium bicarbonate (67.5 mmol/d)
Number of subjects: 171
Study 18940881 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 171
Study 18940881 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium chloride
Number of subjects: 171
Study 18940881 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no bicarbonate)
Number of subjects: 171
Study 16499489 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of long-acting naltrexone 380 mg
Number of subjects: 42
Study 16499489 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of long-acting naltrexone 380 mg every 28 days for a total of 4 doses
Number of subjects: 42
Study 16499489 — intervention group
Group type: COMPARATOR
Intervention: Oral naltrexone 50 mg daily for 5 days followed by IM long-acting naltrexone 380 mg
Number of subjects: 42
Study 16499489 — intervention group
Group type: COMPARATOR
Intervention: Oral naltrexone 50 mg
Number of subjects: 42
Study 15082472 — intervention group
Group type: COMPARATOR
Intervention: Information booklet
Number of subjects: 296
Study 15082472 — intervention group
Group type: COMPARATOR
Intervention: Low sodium, high potassium salt
Number of subjects: 296
Study 15082472 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle prompts for high fruit, vegetable, fibre; and low fat
Number of subjects: 296
Study 11360489 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg nifedipine administered sublingually with a hole in it
Number of subjects: 6
Study 11360489 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg nifedipine administered intranasally with a syringe
Number of subjects: 6
Study 11360489 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg nifedipine administered orally (contents administered orally)
Number of subjects: 6
Study 11360489 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg nifedipine (capsule bitten and swallowed)
Number of subjects: 6
Study 9282082 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (intervention plan to promote positive attitudes toward lactation)
Number of subjects: 202
Study 9282082 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 202
Study 8499937 — intervention group
Group type: EXPERIMENTAL
Intervention: Slurried bananas (SL)
Number of subjects: 8
Study 8499937 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid bananas (SO)
Number of subjects: 8
Study 8499937 — intervention group
Group type: COMPARATOR
Intervention: Artificially sweetened placebo drink (P)
Number of subjects: 8
Study 2949583 — intervention group
Group type: COMPARATOR
Intervention: PN 200-110 (isradipine)
Number of subjects: 50
Study 29931216 — intervention group
Group type: EXPERIMENTAL
Intervention: Romosozumab 210 mg subcutaneously monthly for 12 months
Number of subjects: 245
Study 29931216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study 26285021 — intervention group
Group type: EXPERIMENTAL
Intervention: STAND
Number of subjects: 9
Study 26285021 — intervention group
Group type: EXPERIMENTAL
Intervention: WALK
Number of subjects: 9
Study 26285021 — intervention group
Group type: EXPERIMENTAL
Intervention: CYCLE
Number of subjects: 9
Study 26285021 — intervention group
Group type: COMPARATOR
Intervention: SIT
Number of subjects: 9
Study 24398732 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator training using a transesophageal echocardiography‐mannequin simulator
Number of subjects: 42
Study 24398732 — intervention group
Group type: COMPARATOR
Intervention: Traditional didactic training
Number of subjects: 42
Study 24398732 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator training
Number of subjects: 42
Study 24398732 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator training for clinical anesthesia‐1 residents
Number of subjects: 42
Study 24398732 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator training for residents with no previous transesophageal echocardiography experience
Number of subjects: 42
Study 23594003 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine supplementation
Number of subjects: 1223
Study 23594003 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 1223
Study 23594003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1223
Study 20018587 — intervention group
Group type: EXPERIMENTAL
Intervention: Achilles tendon vibration on stable support
Number of subjects: 20
Study 20018587 — intervention group
Group type: EXPERIMENTAL
Intervention: Achilles tendon vibration on sway-referenced support
Number of subjects: 20
Study 20018587 — intervention group
Group type: COMPARATOR
Intervention: No vibration on stable support
Number of subjects: 20
Study 20018587 — intervention group
Group type: COMPARATOR
Intervention: No vibration on sway-referenced support
Number of subjects: 20
Study 18676897 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation
Number of subjects: 234
Study 18676897 — intervention group
Group type: COMPARATOR
Intervention: Inpatient rehabilitation
Number of subjects: 234
Study 16200586 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofazimine (CFZ) at 100 mg/day
Number of subjects: 33
Study 16200586 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine diphosphate (CDP) at 250 mg/day
Number of subjects: 33
Study 16200586 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofazimine (CFZ)
Number of subjects: 33
Study 16200586 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine diphosphate (CDP)
Number of subjects: 33
Study 12843154 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day
Number of subjects: 968
Study 12843154 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 968
Study 12843154 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 968
Study 10895850 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide/troglitazone combination therapy
Number of subjects: 256
Study 10895850 — intervention group
Group type: COMPARATOR
Intervention: Repaglinide monotherapy
Number of subjects: 256
Study 10895850 — intervention group
Group type: COMPARATOR
Intervention: Troglitazone monotherapy
Number of subjects: 256
Study 8795325 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection pressure of 250 g.cm‐2 (group 2)
Number of subjects: 50
Study 8795325 — intervention group
Group type: COMPARATOR
Intervention: Injection pressure of 140 g.cm‐2 (group 1)
Number of subjects: 50
Study 1354566 — intervention group
Group type: EXPERIMENTAL
Intervention: terfenadine 120 mg (Triludan Forte)
Number of subjects: 0
Study 1354566 — intervention group
Group type: EXPERIMENTAL
Intervention: cetirizine 10 mg (Zirtek)
Number of subjects: 0
Study 1354566 — intervention group
Group type: COMPARATOR
Intervention: loratadine (Clarityn)
Number of subjects: 0
Study 6359989 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized terbutaline (32.5 micrograms)
Number of subjects: 14
Study 6359989 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (400 micrograms/day) plus placebo
Number of subjects: 14
Study 6359989 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (400 micrograms/day) plus terbutaline
Number of subjects: 14
Study 6359989 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (400 micrograms/day)
Number of subjects: 14
Study 6359989 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 28937862 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative oral carbohydrate (Nutricia Preop; n = 45)
Number of subjects: 91
Study 28937862 — intervention group
Group type: COMPARATOR
Intervention: Control group (water flavored with lemon; n = 46)
Number of subjects: 91
Study 26957222 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training program (dumbbell mass-adjusted to 80% of the 1-repetition maximum, performed 3 days a week for 6 weeks)
Number of subjects: 23
Study 26957222 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 23
Study 23775598 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecithinized curcumin (Meriva)
Number of subjects: 160
Study 23775598 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 160
Study 23327031 — intervention group
Group type: EXPERIMENTAL
Intervention: I-gel
Number of subjects: 80
Study 23327031 — intervention group
Group type: COMPARATOR
Intervention: LMA
Number of subjects: 80
Study 20861172 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen
Number of subjects: 49
Study 20861172 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 20861172 — intervention group
Group type: EXPERIMENTAL
Intervention: rs12325817 alleles (0, 1, 2) in premenopausal women
Number of subjects: 49
Study 18551884 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride
Number of subjects: 70
Study 18551884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 16111583 — intervention group
Group type: EXPERIMENTAL
Intervention: 125I vs. 103Pd alone (n = 290)
Number of subjects: 503
Study 16111583 — intervention group
Group type: EXPERIMENTAL
Intervention: 103Pd with 20 Gy vs. 44 Gy supplemental external beam radiotherapy (n = 213)
Number of subjects: 503
Study 16111583 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate rectal radiation doses
Number of subjects: 503
Study 12825239 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulpiride (50 mg, three times per day for three months)
Number of subjects: 100
Study 12825239 — intervention group
Group type: COMPARATOR
Intervention: Placebo (administered three times per day for three months)
Number of subjects: 100
Study 10993857 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 35
Study 10993857 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 35
Study 8869661 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking three cigarettes per hour during a 5.5-hour period
Number of subjects: 9
Study 8869661 — intervention group
Group type: COMPARATOR
Intervention: Non-smoking day
Number of subjects: 9
Study 8869661 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 9
Study 1900383 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet M (70 g sunflower margarine, P:S 1.1)
Number of subjects: 0
Study 1900383 — intervention group
Group type: COMPARATOR
Intervention: Diet B (70 g butter, P:S 0.2)
Number of subjects: 0
Study 6860528 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofensine 25 mg and 50 mg
Number of subjects: 10
Study 6860528 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg
Number of subjects: 10
Study 6860528 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomifensine 75 mg
Number of subjects: 10
Study 6860528 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 10
Study 31735591 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% povidone iodine preparation (single application)
Number of subjects: 0
Study 31735591 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily treatment for 5 days with 10% povidone iodine
Number of subjects: 0
Study 31735591 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 31285147 — intervention group
Group type: EXPERIMENTAL
Intervention: Opicinumab 3 mg/kg
Number of subjects: 419
Study 31285147 — intervention group
Group type: EXPERIMENTAL
Intervention: Opicinumab 10 mg/kg
Number of subjects: 419
Study 31285147 — intervention group
Group type: EXPERIMENTAL
Intervention: Opicinumab 30 mg/kg
Number of subjects: 419
Study 31285147 — intervention group
Group type: EXPERIMENTAL
Intervention: Opicinumab 100 mg/kg
Number of subjects: 419
Study 31285147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 419
Study 28042038 — intervention group
Group type: EXPERIMENTAL
Intervention: Appetitive food cue condition
Number of subjects: 119
Study 28042038 — intervention group
Group type: COMPARATOR
Intervention: Non-food cue condition
Number of subjects: 119
Study 27045864 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenmai injection (SMI)
Number of subjects: 240
Study 27045864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 24914426 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluor Protector (0.1% fluoride varnish)
Number of subjects: 90
Study 24914426 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervitec Plus (1% chlorhexidine‐1% thymol varnish) + Cervitec Gel (0.2% chlorhexidine‐0.2% sodium fluoride)
Number of subjects: 90
Study 24914426 — intervention group
Group type: COMPARATOR
Intervention: Control (toothbrushing only)
Number of subjects: 90
Study 22076422 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80mg, ezetimibe 10mg (Group A)
Number of subjects: 89
Study 22076422 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (Group S)
Number of subjects: 89
Study 20618556 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple peptide complex (TPC)
Number of subjects: 22
Study 20618556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 17123687 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified protocol
Number of subjects: 117
Study 17123687 — intervention group
Group type: COMPARATOR
Intervention: MPDS v11.2 protocol
Number of subjects: 117
Study 11128860 — intervention group
Group type: EXPERIMENTAL
Intervention: 38 mg x kg(‐1) x d(‐1)
Number of subjects: 37
Study 11128860 — intervention group
Group type: COMPARATOR
Intervention: 0 mg x kg(‐1) x d(‐1)
Number of subjects: 37
Study 11128860 — intervention group
Group type: EXPERIMENTAL
Intervention: 76 mg x kg(‐1) x d(‐1)
Number of subjects: 37
Study 9191523 — intervention group
Group type: COMPARATOR
Intervention: Recombinant interferon-alpha (IFN-alpha) at a dose of 3 MU given intramuscularly 3 times a week for 6 months with a 1-month interval between cycles.
Number of subjects: 0
Study 1554195 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 204219 (20 mg)
Number of subjects: 8
Study 1554195 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 3927279 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (dopamine receptor blocker)
Number of subjects: 6
Study 3927279 — intervention group
Group type: COMPARATOR
Intervention: Starvation
Number of subjects: 6
Study 29394147 — intervention group
Group type: EXPERIMENTAL
Intervention: Essen test group
Number of subjects: 1944
Study 29394147 — intervention group
Group type: EXPERIMENTAL
Intervention: Zagreb test group
Number of subjects: 1944
Study 29394147 — intervention group
Group type: COMPARATOR
Intervention: Essen control group
Number of subjects: 1944
Study 26769143 — intervention group
Group type: EXPERIMENTAL
Intervention: mfERG at 5 min after flash fundus photography (FFP)
Number of subjects: 10
Study 26769143 — intervention group
Group type: EXPERIMENTAL
Intervention: mfERG at 15 min after flash fundus photography (FFP)
Number of subjects: 10
Study 26769143 — intervention group
Group type: EXPERIMENTAL
Intervention: mfERG at 30 min after flash fundus photography (FFP)
Number of subjects: 10
Study 26769143 — intervention group
Group type: EXPERIMENTAL
Intervention: mfERG at 45 min after flash fundus photography (FFP)
Number of subjects: 10
Study 26769143 — intervention group
Group type: COMPARATOR
Intervention: mfERG without flash fundus photography (FFP)
Number of subjects: 10
Study 24323615 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrantectomy with axillary lymph node dissection (QUAD)
Number of subjects: 517
Study 24323615 — intervention group
Group type: COMPARATOR
Intervention: Quadrantectomy without axillary lymph node dissection (QU)
Number of subjects: 517
Study 22435864 — intervention group
Group type: EXPERIMENTAL
Intervention: Public health promotion specialist (PHPS) intervention providing a 5‐ to 10‐minute presentation about exercise, heart health, healthy eating on a budget, or weight control.
Number of subjects: 0
Study 22435864 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving usual ED care.
Number of subjects: 0
Study 20585108 — intervention group
Group type: EXPERIMENTAL
Intervention: KNO3 capsules (4 mmol, 12 mmol, or 24 mmol)
Number of subjects: 35
Study 20585108 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (250 mL, 5.5 mmol nitrate)
Number of subjects: 35
Study 20585108 — intervention group
Group type: COMPARATOR
Intervention: KCl (24 mmol)
Number of subjects: 35
Study 20585108 — intervention group
Group type: COMPARATOR
Intervention: Water (250 mL)
Number of subjects: 35
Study 18568474 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice-cream containing Bifidobacterium lactis Bb-12
Number of subjects: 24
Study 18568474 — intervention group
Group type: COMPARATOR
Intervention: Control ice-cream without viable bacteria
Number of subjects: 24
Study 18568474 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 24
Study 16353677 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative shaving (razor)
Number of subjects: 0
Study 16353677 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair removal by clipper or depilatory cream
Number of subjects: 0
Study 16353677 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing of hair removal immediately before surgery
Number of subjects: 0
Study 12050273 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (24 mg/ml)
Number of subjects: 10
Study 12050273 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 12050273 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate
Number of subjects: 10
Study 10690807 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-culture of human embryos on Vero cells
Number of subjects: 384
Study 10690807 — intervention group
Group type: EXPERIMENTAL
Intervention: Embryos transferred on days 5 or 6
Number of subjects: 384
Study 10690807 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen-thawed co-cultured blastocysts
Number of subjects: 384
Study 10690807 — intervention group
Group type: COMPARATOR
Intervention: Conventional day 2 replacements
Number of subjects: 384
Study 8721040 — intervention group
Group type: EXPERIMENTAL
Intervention: Strawberry flavor of ondansetron syrup
Number of subjects: 59
Study 8721040 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape flavor of ondansetron syrup
Number of subjects: 59
Study 8721040 — intervention group
Group type: EXPERIMENTAL
Intervention: No flavor preference
Number of subjects: 59
Study 8721040 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 59
Study 1757609 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% halobetasol propionate ointment
Number of subjects: 120
Study 1757609 — intervention group
Group type: COMPARATOR
Intervention: 0.1% diflucortolone valerate ointment
Number of subjects: 120
Study 31191100 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondominant group (practicing exclusively on the nondominant side)
Number of subjects: 30
Study 31191100 — intervention group
Group type: COMPARATOR
Intervention: Control group (without any instruction regarding the practice side)
Number of subjects: 30
Study 31191100 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral group (practicing with both dominant and nondominant sides)
Number of subjects: 30